Our Publications
Patient Education
Guidelines
Webcasts
Our Publications
Clinical Tools
Webcasts
Expert's Viewpoint
Our Publications
- Calcinase (calcitonin) – Monograph
- Risofos 150 (Risedronate) – Monograph
- Anti-Osteoporosis Therapy in Acute Fracture Situations
- Points to Remember before Administering Rokfos
- COPD Management Beyond the Lungs: Osteoporosis
- Drug Holiday Recommendations for Bisphosphonates
- Rokfos (Zoledronic acid) Datasheet
- Update on Osteoporosis
Key Trials
- Calcium Orotate Increases Serum Calcium and Physical Activity in Postmenopausal Osteoporotic Women
- Efficacy and Safety of ZOL With or Without MTX for Treatment and Prevention of Osteoporosis in RA Patients
- Efficacy of Zoledronic Acid in Patients with Cervical Spondylosis and Osteoporosis after Anterior Cervical Discectomy and Fusion Surgery
- Can Teriparatide Maintain the Higher Body Heights and Prevent Refracture in Osteoporotic Vertebral Compression Fracture Patient After Vertebroplasty?
- Effect of Teriparatide Treatment on Mesenchymal Stromal Cells Functionality in Postmenopausal Osteoporotic Women with Atypical Femoral Fractures
- Post-Hip Fracture, Alendronate Treatment is Associated with Reduced Cardiovascular Risk
- Intranasal Salmon Calcitonin Effectively Reduces Pain Due to Spinal Collapse
- Immediate vs Delayed Teriparatide Therapy for Skeletal Healing of an Atypical Femoral Fracture
- Long-term Alendronate Therapy Demonstrated Sustained Therapeutic Effects in Osteoporotic Postmenopausal Women
- Teriparatide: Safe and Effective in Indian Postmenopausal Women with Osteoporosis
Patient Education
Clinical Tools
Guidelines
- AACE: American Association of Clinical Endocrinologists/ American College of Endocrinology Clinical Practice Guidelines for The Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update (2020)
- Endocrine Society Clinical Practice Guideline: Drug Holiday (2019)
- Endocrine Society Clinical Practice Guideline: Management of Postmenopausal Osteoporosis (2019) (Summary)
- Spanish Society of Pediatric Rheumatology: Expert Panel Consensus Recommendations for Diagnosis and Treatment of Secondary Osteoporosis in Children (2020)
- ACP: Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: Clinical Practice Guideline (2017)
- CDC: Guideline for Surgical Site Infection Prevention (2017)
- NOGG: Guidelines for the Prevention and Treatment of Osteoporosis (2017)
- ACR: Prevention and Management of Glucocorticoid-Induced Osteoporosis (2017)
- ACP: Guidelines for Treatment of Low Bone Density or Osteoporosis in Men and Women (2017)
- AACE/ACE: Guidelines for Diagnosis and Treatment of Postmenopausal Osteoporosis (2016)
- EULAR/EFORT: Recommendations for Fragility Fracture Management in Patients Older Than 50 Years and Prevention of Subsequent Fractures (2016)
- AFP: Recommendations for Diagnosis and Treatment of Osteoporosis (2015)
- NOF: Clinician’s Guide for the Prevention and Treatment of Osteoporosis: Summary (2014)
- NOF: Clinician’s Guide for the Management of Osteoporosis (2014)
- NOF: Guidelines on Management of Osteoporosis (2014)
- NICE: Recommendations on the Management of Hip Fracture in Adults (2011)
Webcasts
- Role of IL-6 Inhibition in Giant Cell Arteritis
- Rheumatoid Arthritis & Lung
- Lumbar Spine Degenerative Disorders
- Phalangeal Fractures: Principles of Management
- Geriatric Ortho Trauma: Principles of Management
- Orthopaedic Surgical Site Infections
- Understanding Proximal Humerus Fractures: Challenges and Treatment Modalities
- Proximal Femur Fractures: Conventional, Controversies and Beyond
- Transcervical Fracture Neck of the Femur
- Lower Limb Trauma–Live Surgery Workshop
- Recent Advances in Joint Replacement – Live Surgery Webcast
- Diagnosis and Management of Early Rheumatoid Arthritis
Our Publications
Our Research
Key Trials
- ORAL STRATEGY Study: Comparative Efficacy of Tofacitinib Monotherapy versus Tofacitinib in Combination with MTX in RA Patients with a Previous Inadequate Response to MTX
- 5-Year Efficacy and Safety Results of TCZ Monotherapy in Patients Who Were Part of the AMBITION Study
- Efficacy and Safety of ZOL With or Without MTX for Treatment and Prevention of Osteoporosis in RA Patients
- GiACTA Trial: Effect of the Tocilizumab on the Rates of Relapse During Glucocorticoid Tapering in Patients with Giant-cell Arteritis
- Adalimumab Treatment Demonstrates Long-term Safety Profile in Japanese Patients with RA
- Continuing versus Withdrawing Adalimumab Therapy in Patients with Active Non-radiographic Axial Spondyloarthritis
Patient Education
Guidelines
- EULAR: Recommendations for Use of Imaging in Diagnosis and Monitoring of Patients with Large Vessel Vasculitis (2017)
- CDC: Guideline for Surgical Site Infection Prevention (2017)
- ACR: Perioperative Antirheumatic Medication Management During Elective Total Hip or Knee Arthroplasty (2017)
- BSR: Systemic Lupus Erythematosus Management in Adults (2017)
- EULAR: Standardized Procedures for Musculoskeletal Ultrasound in Rheumatology (2017)
- ASAS-EULAR: Recommendations for Management of Axial Spondyloarthritis (2016)
- EULAR and GRAPPA: Psoriatic Arthritis Management (2016)
- EULAR: Recommendations for Imaging in Clinical Management of Osteoarthritis Patients (2016)
- NICE: Recommendations for Use of Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab, Tocilizumab and Abatacept in DMARDs Naïve RA Patients or in RA Patients with Conventional DMARDs Failure (2016)
- SSF: Guidelines for Management of Sjögren's Disease: (2016)
- EULAR/ERA-EDTA: Guidelines for ANCA-Associated Vasculitis Management (2016)
- EULAR: Guidelines for Fibromyalgia Management (2016)
- DGRh/AWMF: Evidence-based Recommendations on Axial Spondyloarthritis Diagnostics and Therapy (2016)
- EULAR: Recommendations for Early Arthritis Management (2016)
- BSR/BHPR: Guideline on Prescribing Standard and Biologic DMARDs and Corticosteroids in Pregnancy and Breastfeeding (2016)
- BSR/BHPR: Guideline on Prescribing Analgesics and Other Drugs Used in Rheumatology Practice in Pregnancy and Breastfeeding (2016)
- EULAR: Recommendations for Management of Cardiovascular Disease Risk in Rheumatoid Arthritis Patients and Other Inflammatory Joint Disorders (2016)
- EULAR: Recommendations for Systemic Sclerosis Treatment (2016)
- EULAR/PReS: Standards and Recommendations for the Transitional Care of Young Juvenile-Onset Rheumatic Disease Patients (2016)
- IDSA: Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults (2015)
- ACR: Guideline for Rheumatoid Arthritis Treatment (2015)
- EULAR: Pharmacological Recommendations for the Management of Psoriatic Arthritis (2015)
- International Task Force: Recommendations for Treatment of Spondyloarthritis (2013)
- EULAR: Recommendations on the Management of Medium to High Dose Glucocorticoid Therapy in Rheumatic Diseases (2013)
- EULAR: Recommendations for the Non-Pharmacological Core Management of Hip and Knee Osteoarthritis (2013)
- EULAR: Recommendations for the Management of RA with DMARDs (2013)
- ACR/EULAR: Classification Criteria for Systemic Sclerosis (2013)
- ACR: Non-pharmacologic and Pharmacologic Therapies in Osteoarthritis of the Knee (2012)
- ACR: Non-pharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hip (2012)
- ASAS: Recommendations for Management of Ankylosing Spondylosis (2010)
- 3E Initiative: Evidence Based Recommendations for the Use of Methotrexate (2009)